Clinical trial
Enhancing Immunity to Malaria in Young Children With Effective Chemoprevention
NCT04978272 is registered in ClinicalTrials.gov with Grant Dorsey, M.D, Ph.D. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Enhancing Immunity to Malaria in Young Children With Effective Chemoprevention
- Lead sponsor
- Grant Dorsey, M.D, Ph.D.
- Phase
- Phase 3
- Overall status
- Active, not recruiting
- Start date
- February 8, 2022
- Completion date
- May 5, 2027
- Enrollment
- 924 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.